title: Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.
abstract: Clinical trial data on selective estrogen receptor modulators (SERMs) and aromatase inhibitors (AIs) have demonstrated reduced breast cancer incidence in the prevention setting among high-risk women. We conducted an extensive review of clinical trials and recent published reports of barriers to uptake of breast cancer chemoprevention, to provide health care professionals with information to improve decision-making regarding chemoprevention. Despite the positive results of these trials, uptake of chemoprevention has been low due to barriers in identifying high-risk women, lack of understanding of risks and benefits, as well as concerns about side effects. Interventions designed to increase uptake have met with limited success. Clinicians can support women in informed decision-making about SERMs and AIs by effectively communicating breast cancer risk and enhancing knowledge about the risks and benefits of chemoprevention. Promoting uptake and adherence to chemoprevention holds promise for reducing the public health burden of this disease.
authors: Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
authors: Laura
authors: L
authors: Reimers
authors: Katherine D
authors: KD
authors: Crew
keywords: AI; Aromatase inhibitor; Breast cancer; Chemoprevention; Prevention; Risk; SERM; Selective estrogen receptor modulator
references: Breast Cancer. 2008;15(1):10-6
references: 18224388
references: Cancer Prev Res (Phila). 2011 Sep;4(9):1360-5
references: 21893499
references: Lancet. 2007 Jun 30;369(9580):2134
references: 17604779
references: J Clin Oncol. 2010 Jun 20;28(18):3090-5
references: 20458026
references: Health Expect. 2003 Mar;6(1):3-18
references: 12603624
references: J Clin Oncol. 2008 Mar 20;26(9):1537-43
references: 18349406
references: Cancer Detect Prev. 2007;31(5):375-83
references: 18037249
references: JAMA. 2006 Jun 21;295(23):2742-51
references: 16754728
references: J Natl Cancer Inst. 1999 Sep 15;91(18):1541-8
references: 10491430
references: J Bone Miner Res. 2011 Feb;26(2):397-404
references: 20658564
references: Fam Cancer. 2005;4(2):97-103
references: 15951959
references: Breast Cancer Res Treat. 2010 Feb;119(3):613-20
references: 19908143
references: J Natl Compr Canc Netw. 2010 Oct;8(10):1112-46
references: 20971838
references: Cancer. 2004 May 1;100(9):1800-6
references: 15112259
references: Lancet. 2007 Feb 17;369(9561):559-70
references: 17307102
references: JAMA. 2006 Jun 21;295(23):2727-41
references: 16754727
references: J Clin Oncol. 2003 Feb 15;21(4):602-6
references: 12586795
references: J Natl Cancer Inst. 2007 May 2;99(9):727-37
references: 17470740
references: J Natl Cancer Inst. 2004 Dec 1;96(23):1751-61
references: 15572757
references: N Engl J Med. 2010 Feb 25;362(8):686-96
references: 20181970
references: J Natl Cancer Inst. 2011 Jun 22;103(12):951-61
references: 21562243
references: Ann Surg Oncol. 2001 Aug;8(7):580-5
references: 11508619
references: Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):1032-4
references: 17507634
references: N Engl J Med. 2006 Jul 13;355(2):125-37
references: 16837676
references: Cancer Prev Res (Phila). 2011 Mar;4(3):311-23
references: 21372031
references: J Natl Cancer Inst. 2010 Nov 17;102(22):1706-15
references: 21051656
references: Lancet Oncol. 2006 Aug;7(8):633-43
references: 16887480
references: Stat Med. 2004 Apr 15;23(7):1111-30
references: 15057881
references: J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88
references: 9747868
references: Cancer Prev Res (Phila). 2010 Jun;3(6):696-706
references: 20404000
references: J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62
references: 16288118
references: J Clin Oncol. 2004 Dec 15;22(24):4951-7
references: 15598980
references: Breast Cancer Res Treat. 2011 Jun;127(3):681-8
references: 21442198
references: Cancer Prev Res (Phila). 2011 Sep;4(9):1393-400
references: 21862698
references: J Clin Oncol. 2010 Sep 20;28(27):4120-8
references: 20585090
references: J Natl Cancer Inst. 2011 May 4;103(9):744-52
references: 21483019
references: J Clin Oncol. 1999 Sep;17(9):2659-69
references: 10561339
references: J Clin Oncol. 2005 Mar 10;23(8):1636-43
references: 15755971
references: Cancer. 2005 May 15;103(10):1996-2005
references: 15825209
references: N Engl J Med. 2010 Feb 25;362(8):752-4
references: 20181977
references: J Gen Intern Med. 2006 Jul;21(7):779-85
references: 16808782
references: J Oncol Pract. 2011 Mar;7(2):85-8
references: 21731514
references: Prev Med. 2005 Jul;41(1):7-15
references: 15916987
references: J Clin Oncol. 2011 Jun 10;29(17):2327-33
references: 21537036
references: Cancer. 2005 Jan 1;103(1):209-10
references: 15540238
references: J Natl Cancer Inst. 2003 Apr 2;95(7):526-32
references: 12671020
references: Cancer Prev Res (Phila). 2010 Jun;3(6):686-8
references: 20522798
references: J Clin Oncol. 2010 May 10;28(14):2423-9
references: 20385997
references: N Engl J Med. 2011 Jun 23;364(25):2381-91
references: 21639806
references: Tumori. 1998 May-Jun;84(3):372-5
references: 9678620
references: N Engl J Med. 2005 Dec 29;353(26):2747-57
references: 16382061
references: Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):443-6
references: 20142242
references: JAMA. 1999 Jun 16;281(23):2189-97
references: 10376571
references: Gynecol Oncol. 2001 May;81(2):287-90
references: 11330964
references: J Clin Oncol. 2009 Jul 1;27(19):3235-58
references: 19470930
references: J Am Board Fam Med. 2009 May-Jun;22(3):272-9
references: 19429733
references: Breast Cancer Res Treat. 2010 May;121(1):101-10
references: 20306293
references: Cancer. 2005 Jul 15;104(2):374-9
references: 15937913
references: J Natl Cancer Inst. 2007 Feb 21;99(4):283-90
references: 17312305
references: Ann Fam Med. 2005 May-Jun;3(3):242-7
references: 15928228
references: J Natl Cancer Inst. 2007 Feb 21;99(4):272-82
references: 17312304
references: Lancet Oncol. 2011 May;12(5):496-503
references: 21441069
references: J Natl Cancer Inst. 2007 Dec 5;99(23):1782-92
references: 18042936
references: Expert Rev Anticancer Ther. 2008 Sep;8(9):1377-85
references: 18759690
references: Curr Oncol. 2007 Jun;14(3):89-96
references: 17593981
references: Lancet. 2003 Jan 25;361(9354):296-300
references: 12559863